Showing results (21-30 of 309) with videos related to
Sort By:
Pageof 31
Hematology/Oncology Clinics of North America|May 12, 2000
The fibrinolytic enzyme system. Basic principles and links to venous and arterial thrombosisB WimanPostgraduate Medical Journal|January 1, 1993
Lipids as a coronary risk factor: analysis of hyperlipidaemiasA HamstenEuropean Journal of Biochemistry|September 15, 1975
On the primary structure of human plasminogen and plasmin. Purification and characterization of cyanogen-bromide fragmentsB Wiman, P WallénClinica Chimica Acta; International Journal of Clinical Chemistry|March 14, 1983
A new simple method for determination of C1-esterase inhibitor activity in plasmaB Wiman, T NilssonEuropean Journal of Biochemistry|January 15, 1975
Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatographyB Wiman, P WallénScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1985
A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significanceB Wiman, J ChmielewskaClinical Chemistry|March 1, 1986
Determination of tissue plasminogen activator and its "fast" inhibitor in plasmaJ Chmielewska, B WimanThrombosis and Haemostasis|April 1, 1996
The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Duration of Anticoagulation (DURAC) Trial Study GroupS Schulman, B WimanThrombosis and Haemostasis|April 30, 1986
Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assayB Wiman, M RånbyBiochimica Et Biophysica Acta|July 26, 1982
Purification and characterization of human C1-esterase inhibitorT Nilsson, B WimanPageof 31